DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported a loss of $12.7 million in its second quarter.
The Durham, North Carolina-based company said it had a loss of 6 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The drugmaker posted revenue of $109.3 million in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $98.3 million.
BioCryst shares have increased 17% since the beginning of the year. The stock has dropped almost 1% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX
